Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1986-12-09
1989-03-28
Phillips, Delbert R.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
530330, A61K 3702, C07K 706
Patent
active
048164496
ABSTRACT:
Anti-inflammatory peptides of the formula A-B-C-D-E, useful in treating allergies, autoimmune diseases, and other disorders, and methods for using them are described.
REFERENCES:
patent: 4161522 (1979-07-01), Hamburger
patent: 4171299 (1979-10-01), Hamburger
patent: 4392997 (1983-07-01), Goldberg
patent: 4628045 (1986-12-01), Hahn
Ciccimarra, F., et al., PNAS USA, 72(60)2081-2083 (1975).
Dorrington, Keith J., Immunol. Rev., 41:3-25 (1978).
Dreisin, Robert B., et al., New Engl. J. Med., 298(7):353 (1978).
Fantone, Joseph C., et al., AJP, 107(3):397-418 (1982).
Fisher, Alain, et al., J. Immunol., 126(4):1452-1455 (1981).
Goodwin, James S., et al., Clin. Immonol. Immunopath., 15:106-122 (1980).
Goodwin, J. S., et al., Cancer Immunol, Immunother., 8:3-7 (1980).
Hamburger, Robert. N., Science, 189:389-390 (1975).
Hamburger, R. N., Immunol., 38:781 (1979).
Holdsworth, Stephen R., J. Immunol., 130(2):735-739 (1983).
Hunsicker, L. G., et al., J. Exp. Med., 150:413 (1979).
Jasani, B., et al., Biochem. J., 181:623-632 (1979).
Klein, B., et al., J. Immunol, 48:337 (1983).
Kuehl, Frederick A. Jr., et al., Science, 210:978-984 (1980).
Kumar, Pathologic Basis of Disease, Eds. S. L. Robbins & P. S. Cotran, W. B. Saunders; Philadelphia (1979), p. 304.
Lawrence, E. Clinton, et al., New Engl. J. Med., 302(21):1186 (1980).
Leung, Kam H., et al., J. Immunol., 129(4):1742 (1982).
Melewicz, F. M., et al., Clin. Exp. Immunol., 49:364-370 (1982).
Perez, H. Daniel, et al., Textbook Rheumatology, vol. 1, W. B. Saunders, Philadelphia (1982) 179-194.
Perez-Montfort, Ruy, et al., Mol. Immunol., 19(9):1113-1125 (1982).
Plummer, James M., et al., Fed. Proc. 42:713 (1983).
Samuelsson, Bengt, Science, 220:568 (1983).
Spiegelberg, Hans L., Fed. Proc., 42:122 (1983).
Stanworth, D. R., Mol. Immunol., 19(10)1245-1254 (1982).
Stenson, William F., et al., J. Immunol., 125(1):1 (1980).
Striker, Gary E., et al., J. Exp. Med., 149:127-136 (1979).
Takatsu, Kiyoshi, et al., J. Immunol., 114(6):1838 (1975).
Weiss, S. J., et al., J. Immunol., 129(1):309 (1982).
Hunninghake et al. Clin. Immunol Rev. 1(3) 337 (1981-1982).
Johnson et al., (J. Immunol., 117, 1491 (1975).
Boackle et al., (Nature, 282, 742 (1979).
Prystowksy et al. (Biochemistry 20, 6349 (1981).
Lukas et al. (J. Immunol. 127, 2555 (1981).
Burton et al. Nature 288, 338 (1980).
Veretennikova et al. Int. J. Peptide Protein Res., 17, 430 (1981).
Morgan et al. (Proc. Natl. Acad. Sci, USA 79, 5388 (1982).
Ciccimarra et al. (Proc. Natl. Acad. Sci. USA 72 208 (1975).
Stanworth Mol. Immunol. 19 1245 (1982).
Hamburger, Science 189, 389 (1975).
Biochem J., 180 665 (1979).
Barnett-Foster et al. Mol. Immunol 19 407 (1982).
Barnett-Foster et al. J. Immunol 120, 407 (1978).
Fantone, J. Pathol. 107 397 (1982).
Dreisen et al. N. Engl. J. Med. 298 358 (1978).
Lawrence et al. N. Engl. J. Med. 302 1187 (1980).
Spiegelberg, et al., 42, 124 (1983).
Scott et al., Fed. Proc. 42, 129 (1983).
McMillan, N. Engl. J. Med., 304, 1135 (1981).
Fehr et al. (N. Engl. J. Med., 306, 1254 (1982).
Imbach et al. (Lancet, Jun. 6, 1981, p. 1228).
Oberbarnscheidt et al., Immunol., 35, 151 (1978).
Kolsch et al., Immunol. Rev., 49, 61 (1980).
Fridman et al., Immunol Rev. 56, 51 (1981).
Bich-Thuy, J. Immunol., 129, 150 (1982).
Smolen et al., J. Immunol, 129, 10150 (1982).
Goeken et al., Hum. Immunol., 6, 79 (1983).
Kabelitz et al., Eur. J. Immunol., 12, 687 (1982).
Sakane et al., Proc. Natl. Acad. Sci. U.S.A., 75, 3464 (1978).
Miyasaka et al., J. Clin. Invest., 66, 928 (1980).
James et al., J. Clin. Invest., 66, 1305 (1980).
Hodgkin's Lymphoma (Engleman, et al., J. Clin. Invest., 66 149 (1980).
Smith et al., J. Natl. Cancer Inst., 58, 579 (1977).
Cochrane et al., Lancet 1, 441 (1976).
Douvas, Ann. Immunol. Inst. Pasteur, 132C, 307 (1981).
Ulcerative colitis (Hibi, et al., Clin. Exp. Immunol., 49, 75 (1982).
Hashimoto's Thyroiditis (Calder et al., Clin Exp. Immunol., 14, 153 (1973).
Gonzales-Molina et al., J. Clin. Invest., 59, 616 (1977).
Merrifield J. Am. Chem Soc., 85, 2149-2154 (1963).
Barany & Merrifield in the Peptides Eds. E. Gross & F. Meinehofer, vol. 2 (Academic Press, 1980) p. 2 285.
Synthesis of a Tetrapeptide by R. B. Merrifield, Journal of American Chemical Society (vol. 85, pp. 2 2154 (1963).
Immunetech Pharmaceuticals
Phillips Delbert R.
LandOfFree
Immunotherapeutic anti-inflammatory peptide agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunotherapeutic anti-inflammatory peptide agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunotherapeutic anti-inflammatory peptide agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1659336